Related references
Note: Only part of the references are listed.Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Theaphenon E prevents fatty liver disease and increases CD4+T cell survival in mice fed a high-fat diet
Heidi Coia et al.
CLINICAL NUTRITION (2021)
Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
Feng Gao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
Tao Zuo et al.
GUT (2021)
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort
Jasmohan S. Bajaj et al.
GUT (2021)
Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?
Gabriella Assante et al.
JOURNAL OF HEPATOLOGY (2021)
Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
Lu Pan et al.
DIGESTIVE AND LIVER DISEASE (2021)
IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis
Kristi Basho et al.
JOURNAL OF HEPATOLOGY (2021)
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
Thomas Marjot et al.
JOURNAL OF HEPATOLOGY (2021)
Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points
Marcos F. Fondevila et al.
JOURNAL OF HEPATOLOGY (2021)
Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement
H. Hoel et al.
JOURNAL OF INTERNAL MEDICINE (2021)
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
Luca Perico et al.
NATURE REVIEWS NEPHROLOGY (2021)
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Tamara S. Rodrigues et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Pathways to Severe COVID-19 for People with Obesity
Robert W. O'Rourke et al.
OBESITY (2021)
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis
Jingjiao Li et al.
MED (2021)
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Adaptive immunity: an emerging player in the progression of NAFLD
Salvatore Sutti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
Nadine Gehrke et al.
GASTROENTEROLOGY (2020)
Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease
Silvia Sookoian et al.
GUT (2020)
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus
Weicheng Liang et al.
GUT (2020)
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
Guido Carpino et al.
HEPATOLOGY (2020)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study
Lei Pan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Meijuan Zheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Will Complement Inhibition Be the New Target in Treating COVID-19-Related Systemic Thrombosis?
Courtney M. Campbell et al.
CIRCULATION (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization
Tao Zuo et al.
GASTROENTEROLOGY (2020)
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
Giovanni Targher et al.
GUT (2020)
Characterization of the immune cell landscape of patients with NAFLD
Tom Diedrich et al.
PLOS ONE (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
Yu-Jie Zhou et al.
JOURNAL OF HEPATOLOGY (2020)
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Dong Ji et al.
JOURNAL OF HEPATOLOGY (2020)
ACE2 activators for the treatment of COVID 19 patients
Rafael Rodriguez-Puertas
JOURNAL OF MEDICAL VIROLOGY (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Potential implications of COVID-19 in non-alcoholic fatty liver disease
Grietje H. Prins et al.
LIVER INTERNATIONAL (2020)
Liver injury during highly pathogenic human coronavirus infections
Ling Xu et al.
LIVER INTERNATIONAL (2020)
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
Hansheng Xie et al.
LIVER INTERNATIONAL (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Bioinformatic analysis and identi fication of single -stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
Mario Adan Moreno-Eutimio et al.
MICROBES AND INFECTION (2020)
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Ruochen Zang et al.
SCIENCE IMMUNOLOGY (2020)
The Perfect Storm: Coronavirus (Covid-19) Pandemic Meets Overfat Pandemic
Philip B. Maffetone et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes
Christina C. Price et al.
CHEST (2020)
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza
Silan Gu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
G. Targher et al.
DIABETES & METABOLISM (2020)
Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge
Tao Zuo et al.
GASTROENTEROLOGY (2020)
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
Michael R. Garvin et al.
ELIFE (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Presence of Genetic Variants Among Young Men With Severe COVID-19
Caspar I. van der Made et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab
Austin R. Morrison et al.
JOURNAL OF AUTOIMMUNITY (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Jatin Machhi et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
Isabel Gomez-Hurtado et al.
LIVER INTERNATIONAL (2020)
Metabolic-associated fatty liver disease is associated with severity of COVID-19
Yu-Jie Zhou et al.
LIVER INTERNATIONAL (2020)
Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
Kenneth I. Zheng et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
Julien Carvelli et al.
NATURE (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis
Vincenzo Cardinale et al.
DIGESTIVE AND LIVER DISEASE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Evaluation of safety, efficacy, tolerability, and treatment-related outcomes of type I interferons for human coronaviruses (HCoVs) infection in clinical practice: An updated critical systematic review and meta-analysis
Chengjun Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Bruno M. Tomazini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Reply to: correspondence regarding A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement Bringing evidence to the NAFLD-MAFLD debate
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
Francesco Perrone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
Sara Della Torre
FRONTIERS IN ENDOCRINOLOGY (2020)
Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19
Yapeng Su et al.
CELL (2020)
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
Jamie O'Hara et al.
JHEP REPORTS (2020)
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study
Li Tan et al.
MED (2020)
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
Natella Maglakelidze et al.
PULMONARY THERAPY (2020)
Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin in 1142 patients with coronavirus disease 2019: a systematic review and meta-analysis
Lei Pei et al.
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ (2020)
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
Kyung Mok Sohn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Dennis McGonagle et al.
LANCET RHEUMATOLOGY (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
Praveen Sharma et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis
Ting Wu et al.
AGING AND DISEASE (2020)
COVID-19, coronavirus, SARS-CoV-2 and the small bowel
Klaus Moenkemueller et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2020)
Mesenteric lymph node CD4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease
Lin Su et al.
CELLULAR IMMUNOLOGY (2019)
Mesenteric adipose tissue B lymphocytes promote local and hepatic inflammation in non-alcoholic fatty liver disease mice
Zhe Wu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway
Yanbo Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC
Kam-Leung Siu et al.
FASEB JOURNAL (2019)
Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis
Sumit Kar et al.
PLOS ONE (2019)
Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
Natalie Stiglund et al.
FRONTIERS IN IMMUNOLOGY (2019)
SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes
Chong-Shan Shi et al.
CELL DEATH DISCOVERY (2019)
Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution
Joel T. Haas et al.
NATURE METABOLISM (2019)
Sexual Dimorphism in Innate Immunity
Sebastien Jaillon et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
Sander Lefere et al.
JHEP REPORTS (2019)
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)
Stefania Bruzzi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Immune Responses in the Liver
Paul Kubes et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development
Zachary J. Brown et al.
CELL DEATH & DISEASE (2018)
Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1
Ji-Hyun Lee et al.
SCIENTIFIC REPORTS (2018)
Distinct Housing Conditions Reveal a Major Impact of Adaptive Immunity on the Course of Obesity-Induced Type 2 Diabetes
Julia Sbierski-Kind et al.
FRONTIERS IN IMMUNOLOGY (2018)
Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease
Jingjing Cai et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
Ruth C. R. Meex et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans
Maria Eugenia Inzaugarat et al.
PLOS ONE (2017)
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity
Elisa Alchera et al.
TRANSLATIONAL RESEARCH (2017)
Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease
Wenjing Luo et al.
SCIENTIFIC REPORTS (2017)
The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease
Magdalena Swiderska et al.
CLINICAL AND EXPERIMENTAL HEPATOLOGY (2017)
The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice
Beihui He et al.
BMC IMMUNOLOGY (2017)
The role of contact system in septic shock: the next target? An overview of the current evidence
Henrique Nicola
JOURNAL OF INTENSIVE CARE (2017)
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver
Monika Rau et al.
JOURNAL OF IMMUNOLOGY (2016)
Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease
Tim Hendrikx et al.
BMC MEDICINE (2016)
Innate Immunity and Inflammation in NAFLD/NASH
Marco Arrese et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model
Ying Hu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven M. Francque et al.
JOURNAL OF HEPATOLOGY (2016)
NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis
Chi Ma et al.
NATURE (2016)
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
Xingyong Wan et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD
Johannie du Plessis et al.
PLoS One (2016)
Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease
Sokho Kim et al.
SCIENTIFIC REPORTS (2016)
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease
Maria Teresa Arias-Loste et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Bacterial cell wall components regulate adipokine secretion from visceral adipocytes
Risa Taira et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2015)
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
Gadi Lalazar et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2015)
Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease
Azza Karrar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome
Jose L. Nieto-Torres et al.
VIROLOGY (2015)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
Astaxanthin prevents and reverses diet-induced insulin resistance and steatohepatitis in mice: A comparison with vitamin E
Yinhua Ni et al.
SCIENTIFIC REPORTS (2015)
The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
Maria Teresa Arias-Loste et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model
Akitoshi Douhara et al.
MOLECULAR MEDICINE REPORTS (2015)
Association between Complement C3 and Prevalence of Fatty Liver Disease in an Adult Population: A Cross-Sectional Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study
Qiyu Jia et al.
PLOS ONE (2015)
Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
Luisa Vonghia et al.
PLOS ONE (2015)
Metabolic Activation of lntrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
Monika Julia Wolf et al.
CANCER CELL (2014)
Adaptive Immune Responses Triggered by Oxidative Stress Contribute to Hepatic Inflammation in NASH
Salvatore Sutti et al.
HEPATOLOGY (2014)
Toll-Like Receptor 7-Mediated Type I Interferon Signaling Prevents Cholestasis- and Hepatotoxin-Induced Liver Fibrosis
Yoon Seok Roh et al.
HEPATOLOGY (2014)
Mice Lacking Natural Killer T Cells Are More Susceptible to Metabolic Alterations following High Fat Diet Feeding
Brittany V. Martin-Murphy et al.
PLOS ONE (2014)
Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
Filip M. Segers et al.
PLOS ONE (2014)
IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet
Xiao-Yu Luo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
Maitreyi Raman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice
Justin R. Henning et al.
HEPATOLOGY (2013)
Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice
Kouichi Miura et al.
HEPATOLOGY (2013)
Natural killer cells in liver disease
Zhigang Tian et al.
HEPATOLOGY (2013)
B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease
Teruki Miyake et al.
HEPATOLOGY INTERNATIONAL (2013)
Immune and inflammatory pathways in NASH
Michal Ganz et al.
HEPATOLOGY INTERNATIONAL (2013)
NKT-cell subsets: Promoters and protectors in inflammatory liver disease
Vipin Kumar
JOURNAL OF HEPATOLOGY (2013)
Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome
Takeshi Nishida et al.
LABORATORY INVESTIGATION (2013)
Molecular Interactions between NAFLD and Xenobiotic Metabolism
Adviti Naik et al.
Frontiers in Genetics (2013)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
A High-Fat Diet Is Associated With Endotoxemia That Originates From the Gut
Swaroop Pendyala et al.
GASTROENTEROLOGY (2012)
Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network
Raj Vuppalanchi et al.
HEPATOLOGY INTERNATIONAL (2012)
The Role of Innate Cells Is Coupled to a Th1-Polarized Immune Response in Pediatric Nonalcoholic Steatohepatitis
Nazarena E. Ferreyra Solari et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
Saswata Talukdar et al.
NATURE MEDICINE (2012)
Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors
Mohan R. Dasu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis
Cecilia Soderberg et al.
APMIS (2011)
Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
David A. Brenner et al.
HEPATOLOGY RESEARCH (2011)
Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis
Maria Eugenia Inzaugarat et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease
Anna Kotronen et al.
LIVER INTERNATIONAL (2011)
Intrahepatic natural killer T cell populations are increased in human hepatic steatosis
Michael Adler et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease
Valerio Nobili et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease
Teruki Miyake et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
Adeline Bertola et al.
PLOS ONE (2010)
JNK regulation of hepatic manifestations of the metabolic syndrome
Mark J. Czaja
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Role of liver-infiltrating CD3(+)CD56(+) natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease
Kazuto Tajiri et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Activation of the Complement System in Human Nonalcoholic Fatty Liver Disease
Sander S. Rensen et al.
HEPATOLOGY (2009)
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
Craig D. Fisher et al.
DRUG METABOLISM AND DISPOSITION (2009)
Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis
Hideki Niwa et al.
HEPATOLOGY RESEARCH (2007)
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes
S. J. Creely et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
COX-2 induction in mice with experimental nutritional steatohepatitis:: Role as pro-inflammatory mediator
J Yu et al.
HEPATOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease
ZP Li et al.
HEPATOLOGY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis
E Albano et al.
GUT (2005)
Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis
SJ Coder et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease
LA Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates
P Loria et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo et al.
HEPATOLOGY (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
